Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Merck forecasts hit by halt in China vaccine shipments
Merck blamed the lower than expected forecast on the decision to pause shipments of its Gardasil vaccine to China until at least mid-year. Gardasil is given to patients to prevent human papillomavirus,
Merck pauses Gardasil shipments to China, hitting its 2025 outlook
Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong fourth-quarter profit on sales of cancer drug Keytruda.
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Merck Pauses Gardasil Vaccine Shipments to China
Merck halted shipments to China of its cancer-preventing Gardasil vaccine, with the pause expected to last at least through mid-year. Chris Shibutani, senior biotech analyst of global investment research at Goldman Sachs,
Merck's 2025 outlook falls on cancer vaccine China shipment pause
Gardasil, a vaccine that prevents cancers caused by human papillomavirus has faced declining sales in China, a key market for the product. Merck's shipping pause aims to reduce excess inventory and stabilize the financial position of Merck's commercialization partner in China,
Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job
Shares of vaccine makers and packaged food companies fell on Tuesday after President Donald Trump's pick for U.S. health ...
Uganda starts clinical trial of vaccine for Sudan strain of Ebola amid new outbreak
Uganda has begun a clinical trial of a vaccine against the Sudan strain of Ebola following an outbreak that has killed one ...
KJZZ58m
Animal Valley fever vaccine may be available by the end of 2025
A Valley fever vaccine for animals may be available by the end of the year. Dr. John Galgiani, founder of the Valley Fever Center for Excellence at the University of Arizona, says they discovered a ...
Uganda begins Ebola vaccine trial after new outbreak kills a nurse and infects 2 other people
Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in ...
Legal experts say RFK Jr.'s move to give financial interest in vaccine lawsuits to family is 'not unusual'
Amid scrutiny over Robert F. Kennedy Jr.'s pledge to divest his financial stake in vaccine lawsuits to his family, legal ...
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
Shares of vaccine companies fell after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead the ...
Democratic Senators demand health pick Kennedy's recusal from vaccine matters if confirmed
Two U.S. senators who will vote this week on whether to advance Robert F. Kennedy Jr.'s nomination as the top U.S. health ...
Bill Gates shares his thoughts on vaccine backlash, Intel’s woes and Google’s antitrust battle
Although Microsoft founder Bill Gates sat down for an interview with The Associated Press to discuss his new memoir, “Source ...
Researchers take step toward creating salmonella vaccine
Salmonella might seem like a mild inconvenience to some, but for sensitive groups, it can prove dangerous or deadly. In fact, ...
Plan for WV school vaccine exemptions is done, but document is kept private
The first step in Gov. Patrick Morrisey’s plan to allow religious exemptions to the state’s school vaccine laws is apparently ...
BioPharma Dive14h
RFK Jr. secured support of key Republican with vaccine pledges
Sen. Bill Cassidy, whose “yes” vote advanced Kennedy’s nomination as health secretary, said Kennedy promised to maintain a ...
Pfizer beats profit estimates on heart disease drug, COVID vaccine sales
(Reuters) -Drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Thursday, boosted by cost-cutting, a ...